CDC7 and cancer: Inhibition of CDC7 kinase by small-molecule inhibitors (12), anti-CDC7 antibody microinjection (13), or RNA silencing (14) induces antiproliferation in many cancer cell or immortal cell lines in vitro. Thus, CDC7 inhibitors have potential as novel cancer treatments.